Be The Match BioTherapies to exhibit at 59th ASH Annual Meeting & Exposition Dec. 9-11
Nov. 2017 – Be The Match BioTherapies® will be exhibiting at the 2017 ASH Annual Meeting in Atlanta, Ga., Dec. 9-11, 2017.
Be The Match BioTherapies to present at Cell Therapy Manufacturing & Gene Therapy Congress on Dec. 6
Nov. 2017 – On Wednesday, Dec. 6, Amy Ronneberg, MBA, president of Be The Match BioTherapies, will present “Navigating the cell therapy supply chain – when exceptions are the norm,” at the Cell Therapy Manufacturing & Gene Therapy Congress in Amsterdam.
Be The Match BioTherapies Launches New Technology Platform for Cell Therapy Supply Chain Management
Oct. 2017 – Be The Match BioTherapies® today announced the launch of a new, implementation-ready technology platform for cell and gene therapies in clinical development or poised for commercialization.
Be The Match BioTherapies Presents at CAR-TCR Summit 2017 on Sept. 6
Sept. 2017 — Be The Match BioTherapies is participating in the CAR-TCR Summit 2017 in Boston, Mass., Sept. 5-8, 2017.
Be The Match BioTherapies Presents at Future Cell Therapy Commercialization Summit 2017
June 2017 — Be The Match BioTherapies® participated in the Future Cell Therapy Commercialization Summit 2017 in Boston, Mass., June 26-27.
Associate Bioinformatics Scientist participates in the first AI Genomics Hackathon
June 2017 — An Associate Bioinformatics Scientist for Be The Match BioTherapies® and the National Marrow Donor Program® (NMDP)/Be The Match® attended the first Artificial Intelligence (AI) Hackathon at Google’s Launchpad in San Francisco.
Be The Match BioTherapies Announces Collaboration Agreement with Magenta Therapeutics
May 2017 — Be The Match BioTherapies announced that it has entered into a strategic partnership with Magenta Therapeutics that aims to expand the use of stem cell transplant to disease indications including immune and blood-based diseases.
Be The Match BioTherapies Presents at Phacilitate Cell & Gene Therapy World 2017
Jan. 2017 — Be The Match BioTherapiesSM and our parent company, National Marrow Donor Program® (NMDP)/Be The Match®, participated in the Phacilitate Cell & Gene Therapy World 2017 in Miami, Fla.
National Marrow Donor Program (NMDP)/Be The Match Forms New Cellular Therapies Subsidiary
Jan. 2016 — NMDP/Be The Match announced the formation of Be The Match BioTherapies, a subsidiary that will focus on partnering with organizations pursuing new life-saving treatments in cellular therapy.
For media inquiries, contact firstname.lastname@example.org.
Are you attending one of the events below? Contact us – we’d like to connect with you at the event and learn how we can partner together.
Dec. 6-7, 2017
Dec. 9-12, 2017
Jan. 23-25, 2018
Feb. 21-25, 2018
Salt Lake City, Utah